Adjuvant systemic therapy for patients with germline BRCA1/2 mutations

被引：0
|
作者：
Tutt, A. [1 ]
机构：
[1] Kings Coll London, Inst Canc Res, London, England
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 4.4
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [41] Germline testing in community oncology patients with somatic BRCA1/2 mutations.
    Principe, Kate
    Nichols, Trisha
    Patel, Gayle
    Bunnell, Ann
    Fisher, Camille
    Lord, Katharine
    Carlisle, Steven
    Torres, Vanessa
    Wilfong, Lalan S.
    Kodali, Dhatri
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
    Rajwa, Pawel
    Quhal, Fahad
    Pradere, Benjamin
    Gandaglia, Giorgio
    Ploussard, Guillaume
    Leapman, Michael S.
    Gore, John L.
    Paradysz, Andrzej
    Tilki, Derya
    Merseburger, Axel S.
    Morgan, Todd M.
    Briganti, Alberto
    Palapattu, Ganesh S.
    Shariat, Shahrokh F.
    NATURE REVIEWS UROLOGY, 2023, 20 (04) : 205 - 216
  • [43] Frequency of Germline BRCA1/2 Mutations in Unselected Patients With Colorectal Cancer Reply
    Yurgelun, Matthew B.
    Syngal, Sapna
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (22) : 2589 - +
  • [44] Prevalence of germline mutations in BRCA1/2 in patients from northeastern Brazil.
    Picanco-Albuquerque, Clarissa Gondim
    de Lima Silva-Fernandes, Isabelle Joyce
    Barbosa Bezerra, Maria Julia
    dos Santos Luciano, Maria Claudia
    Sant'Ana, Rosane Oliveira
    de Barros Silva, Paulo Goberlanio
    Alves Lima, Marcos Venicio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Breast cancer survival of young patients: The impact of BRCA1/2 germline mutations
    Schmidt, M. K.
    Van den Broek, A. J.
    Tollenaar, R. A. E. M.
    Van Leeuwen, F. E.
    Van 't Veer, L. J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S474 - S474
  • [46] Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
    Pawel Rajwa
    Fahad Quhal
    Benjamin Pradere
    Giorgio Gandaglia
    Guillaume Ploussard
    Michael S. Leapman
    John L. Gore
    Andrzej Paradysz
    Derya Tilki
    Axel S. Merseburger
    Todd M. Morgan
    Alberto Briganti
    Ganesh S. Palapattu
    Shahrokh F. Shariat
    Nature Reviews Urology, 2023, 20 : 205 - 216
  • [47] Absence of germline BRCA1 mutations in familial pancreatic cancer patients
    Axilbund, Jennifer E.
    Argani, Pedram
    Kamiyama, Mihoko
    Palmisano, Emily
    Raben, Marian
    Borges, Michael
    Brune, Kieran A.
    Goggins, Michael
    Hruban, Ralph H.
    Klein, Alison P.
    CANCER BIOLOGY & THERAPY, 2009, 8 (02) : 131 - 135
  • [48] Evaluation of BRCA1 antibodies as a screening tool for germline BRCA1 mutations.
    Worsham, MJ
    Barnabas, N
    Raju, U
    Pals, G
    Wolman, SR
    Herrington, CS
    Zarbo, RJ
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (05): : ST1 - ST1
  • [49] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    MODERN PATHOLOGY, 2019, 32
  • [50] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    LABORATORY INVESTIGATION, 2019, 99
12345